Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05692323 · ClinicalTrials.gov registry record · NA
A Supervised Prehabilitation Program for Patients With Pancreatic Cancer
A NA study of Pancreas Cancer, sponsored by Cedars-Sinai Medical Center.
- Active
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT05692323 is a NA study of Pancreas Cancer that is active but no longer recruiting, run by Cedars-Sinai Medical Center. The registered enrollment target is 16 participants, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05692323, a NA study of Pancreas Cancer, is active but no longer recruiting, sponsored by Cedars-Sinai Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.
Conditions Studied
Interventions
- OTHER PREHAB
Study Locations (1)
California
- Cedars-Sinai Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05692323
The ClinicalTrials.gov registry entry for NCT05692323 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 907-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreas Cancer appearing as the primary indexed condition, and to 1 intervention - of which PREHAB is the first listed.
NCT05692323 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05692323 about?
NCT05692323 is a clinical study titled "A Supervised Prehabilitation Program for Patients With Pancreatic Cancer". The purpose of this study is to assess the use of an exercise program in people with pancreatic cancer.
What is the current status of trial NCT05692323?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2023-04-04. Estimated completion is 2027-04-01.
What conditions does trial NCT05692323 study?
This clinical trial studies the following conditions: Pancreas Cancer.
What interventions are being tested in trial NCT05692323?
The interventions under investigation include: PREHAB (OTHER).
Who is sponsoring clinical trial NCT05692323?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05692323 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Promoting CT Engagement for Pancreatic Cancer With App
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
RECRUITING · NA
-
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.